Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis
PublisherPublic Library of Science
MetadataShow full item record
AbstractTularemia, also known as rabbit fever, is a severe zoonotic disease in humans caused by the gram-negative bacterium Francisella tularensis (Ft). While there have been a number of attempts to develop a vaccine for Ft, few candidates have advanced beyond experiments in inbred mice. We report here that a prime-boost strategy with aerosol delivery of recombinant live attenuated candidate Ft S4?aroD offers significant protection (83% survival) in an outbred animal model, New Zealand White rabbits, against aerosol challenge with 248 cfu (11 LD50) of virulent type A Ft SCHU S4. Surviving rabbits given two doses of the attenuated strains by aerosol did not exhibit substantial post-challenge fevers, changes in erythrocyte sedimentation rate or in complete blood counts. At a higher challenge dose (3,186 cfu; 139 LD50), protection was still good with 66% of S4?aroD-vaccinated rabbits surviving while 50% of S4?guaBA vaccinated rabbits also survived challenge. Pre-challenge plasma IgG titers against Ft SCHU S4 corresponded with survival time after challenge. Western blot analysis found that plasma antibody shifted from predominantly targeting Ft O-antigen after the prime vaccination to other antigens after the boost. These results demonstrate the superior protection conferred by a live attenuated derivative of virulent F. tularensis, particularly when given in an aerosol prime-boost regimen. Copyright 2018 O'Malley et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85055159097&doi=10.1371%2fjournal.pone.0205928&partnerID=40&md5=d1345288dfd11952d451e8279e28bc1c; http://hdl.handle.net/10713/9406
- Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.
- Authors: Reed DS, Smith LP, Cole KS, Santiago AE, Mann BJ, Barry EM
- Issue date: 2014 May
- Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.
- Authors: Stinson E, Smith LP, Cole KS, Barry EM, Reed DS
- Issue date: 2016 Oct
- A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
- Authors: Jia Q, Bowen R, Sahakian J, Dillon BJ, Horwitz MA
- Issue date: 2013 May
- Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
- Authors: Richard K, Mann BJ, Qin A, Barry EM, Ernst RK, Vogel SN
- Issue date: 2017 Mar
- Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
- Authors: Tian D, Uda A, Park ES, Hotta A, Fujita O, Yamada A, Hirayama K, Hotta K, Koyama Y, Azaki M, Morikawa S
- Issue date: 2018 Jan